Pyoderma Gangrenosum A Comparison of Typical and Atypical Forms with an Emphasis on Time to Remission. Case Review of 86 Patients from 2 Institutions

Pyoderma gangrenosum (PG) is an idiopathic, inflammatory, ulcerative disease of undetermined cause. The diagnosis is based on clinical and pathologic features and requires exclusion of conditions that produce ulcerations. An atypical bullous variant (atypical pyoderma gangrenosum, APG) exists with clinical features similar to those of Sweet syndrome. Because PG is a rare disease, few large case series have been reported. Pyoderma gangrenosum was first recognized as a unique disease entity in the first half of the 20th century. Cumulative knowledge of PG is based on a handful of case series and multiple individual case reports. To augment that knowledge, we present our experience with a large number of patients over a significant time. We performed a retrospective analysis of the medical records of 86 patients with PG who were evaluated and treated over 12 years at 2 university-based dermatology departments. The mean (+/- standard deviation) age of onset of PG and APG, respectively, was 44.6 +/- 19.7 years and 52.2 +/- 15.3 years. Lower extremity involvement was most common in PG, whereas upper extremity involvement was most common in APG. Associated relevant systemic diseases were seen in 50% of patients. Inflammatory bowel disease was the most common association in patients with PG, whereas hematologic disease or malignancy was most common in those with APG. Although a few patients were managed with local measures or nonimmunosuppressive treatment, the majority required oral corticosteroid therapy, often with systemic immunosuppressive treatment. PG patients required a mean 11.5 +/- 11.1 months of treatment to achieve remission compared with 9.0 +/- 13.7 months for patients with APG. Five patients (5.8%) had disease that was extremely refractory to multiple intensive therapies. The prognosis and disease associations for PG and APG appear to be different. Compared with PG, APG is more often associated with hematologic disease or malignancy, and remits more quickly.

[1]  R. Ayyala,et al.  Corneal melting and scleromalacia perforans in a patient with pyoderma gangrenosum and acute myeloid leukemia. , 1998, Ophthalmic surgery and lasers.

[2]  S. Burge,et al.  Lesson of the week: Early diagnosis of pyoderma gangrenosum is important to prevent disfigurement , 1998, BMJ.

[3]  P. Driesch,et al.  Pyoderma gangrenosum: a report of 44 cases with follow‐up , 1997, The British journal of dermatology.

[4]  J. Gamez-Nava,et al.  Intravenous cyclophosphamide pulses in pyoderma gangrenosum: an open trial. , 1997, The Journal of rheumatology.

[5]  J. Callen,et al.  Chlorambucil is an effective corticosteroid-sparing agent for recalcitrant pyoderma gangrenosum. , 1996, Journal of the American Academy of Dermatology.

[6]  V. Ho,et al.  Treatment of pyoderma gangrenosum. , 1996, Journal of the American Academy of Dermatology.

[7]  A. Teitel Treatment of pyoderma gangrenosum with methotrexate. , 1996, Cutis.

[8]  C. Samlaska,et al.  Pyoderma gangrenosum and cranial osteolysis: case report and review of the paediatric literature , 1995, The British journal of dermatology.

[9]  A. Moreau,et al.  RECURRING POSTOPERATIVE PYODERMA GANGRENOSUM , 1995, International journal of dermatology.

[10]  K. Kato,et al.  Pyoderma Gangrenosum with Systemic Involvement , 1995, The Journal of dermatology.

[11]  Philip R. Cohen,et al.  Pyoderma gangrenosum in an HIV-infected patient. , 1995, Journal of American Academy of Dermatology.

[12]  M. Vignon-Pennamen,et al.  Neutrophilic disease: a review of extracutaneous neutrophilic manifestations , 1995 .

[13]  J. Tjandra,et al.  Parastomal pyoderma gangrenosum in inflammatory bowel disease , 1994, Diseases of the colon and rectum.

[14]  G. Micali,et al.  CEPHALIC PYODERMA GANGRENOSUM (PG)‐LIKE LESIONS AS A PRESENTING SIGN OF WEGENER'S GRANULOMATOSIS , 1994, International journal of dermatology.

[15]  J. R. Hughes,et al.  Pyoderma gangrenosum in a patient with rheumatoid arthritis responding to treatment with cyclosporin A. , 1994, British Journal of Rheumatology.

[16]  B. Cairns,et al.  Peristomal pyoderma gangrenosum and inflammatory bowel disease. , 1994, Archives of surgery.

[17]  P. Martínez-Osuna,et al.  Intravenous cyclophosphamide pulses in the treatment of pyoderma gangrenosum associated with rheumatoid arthritis: report of 2 cases and review of the literature. , 1994, The Journal of rheumatology.

[18]  V. Goulden,et al.  Pyoderma gangrenosum associated with paroxysmal nocturnal haemoglobinuria , 1994, Clinical and experimental dermatology.

[19]  J. Graham,et al.  Pyoderma Gangrenosum in Infants and Children , 1994, Pediatric dermatology.

[20]  M. Johnson,et al.  Leukocyte colony-stimulating factors. A review of associated neutrophilic dermatoses and vasculitides. , 1994, Archives of dermatology.

[21]  G. Koester,et al.  Bullous pyoderma gangrenosum. , 1993, Journal of the American Academy of Dermatology.

[22]  J. Olerud,et al.  Pyoderma gangrenosum after coronary artery bypass grafting. , 1993, The Annals of thoracic surgery.

[23]  T. Lotti,et al.  RECALCITRANT PYODERMA GANGRENOSUM RESPONSIVE TO CYCLOSPORINE , 1993, International journal of dermatology.

[24]  H. Hedayati,et al.  Rheumatoid arthritis, relapsing polychondritis, and pyoderma gangrenosum evolving into non-Hodgkin's lymphoma , 1993, The Journal of the American Osteopathic Association.

[25]  J. H. Haseman,et al.  The evolution of pyoderma gangrenosum. A clinicopathologic correlation. , 1993, The American Journal of dermatopathology.

[26]  R. Brown,et al.  Bilateral Pyoderma Gangrenosum of the Hand: Treatment with Dapsone , 1993, Journal of hand surgery.

[27]  F. Kerdel,et al.  Successful treatment of aggressive pyoderma gangrenosum with pulse steroids and chlorambucil. , 1992, Journal of the American Academy of Dermatology.

[28]  C. Lebbé,et al.  Steroid-responsive pyoderma gangrenosum with vulvar and pulmonary involvement. , 1992, Journal of the American Academy of Dermatology.

[29]  M. Keltz,et al.  Peristomal pyoderma gangrenosum. , 1992, Journal of the American Academy of Dermatology.

[30]  H. Trau,et al.  TREATMENT OF PYODERMA GANGRENOSUM WITH CLOFAZIMINE , 1992, International journal of dermatology.

[31]  S. Walton,et al.  PYODERMA GANGRENOSUM: ASSOCIATIONS REVISITED , 1992, International journal of dermatology.

[32]  C. Griffiths,et al.  Treatment of pyoderma gangrenosum with cyclosporine. , 1992, Archives of dermatology.

[33]  C.S. McCalmont,et al.  Vulvar pyoderma gangrenosum , 1991, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[34]  R. Rapini Cytotoxic Drugs in the Treatment of Skin Disease , 1991, International journal of dermatology.

[35]  D. Mahoney,et al.  Pyoderma Gangrenosum in Childhood Leukemia , 1990, Pediatric dermatology.

[36]  J. Voorhees,et al.  Management of patients and side effects during cyclosporine therapy for cutaneous disorders. , 1990, Journal of the American Academy of Dermatology.

[37]  J. Callen,et al.  Pyoderma gangrenosum and related disorders. , 1989, Advances in dermatology.

[38]  J. Callen,et al.  Chlorambucil--an effective corticosteroid-sparing therapy for pyoderma gangrenosum. , 1989, Journal of the American Academy of Dermatology.

[39]  J. Uetrecht Dapsone and sulfapyridine. , 1989, Clinics in dermatology.

[40]  G. Lazarus,et al.  Present status of pyoderma gangrenosum. Review of 21 cases. , 1989, Archives of dermatology.

[41]  J. Jorizzo,et al.  Neutrophilic vascular reactions. , 1988, Journal of the American Academy of Dermatology.

[42]  H. Mensing Clofazimine in dermatitis ulcerosa (pyoderma gangrenosum). Open clinical trial. , 1988, Dermatologica.

[43]  D. Winfield,et al.  Atypical bullous pyoderma gangrenosum associated with myeloid malignancies. , 1987, Journal of clinical pathology.

[44]  F. Goldstein,et al.  Intralesional steroid therapy of pyoderma gangrenosum. , 1985, Journal of clinical gastroenterology.

[45]  L. Green,et al.  Pyoderma gangrenosum and chronic persistent hepatitis. , 1985, Journal of the American Academy of Dermatology.

[46]  W. Su,et al.  Pyoderma gangrenosum: a review of 86 patients. , 1985, The Quarterly journal of medicine.

[47]  A. McEvoy,et al.  Severe steroid responsive pneumonitis associated with pyoderma gangrenosum and ulcerative colitis. , 1985, Thorax.

[48]  H. Perry,et al.  Pyoderma gangrenosum in childhood. , 1984, Archives of dermatology.

[49]  A. Zina,et al.  Pyoderma gangrenosum associated with selective hereditary IgA deficiency. , 1984, Dermatologica.

[50]  F. Wollheim Acute and long-term complications of corticosteroid pulse therapy. , 1984, Scandinavian journal of rheumatology. Supplement.

[51]  G. Lazarus,et al.  Pulse therapy. Therapeutic efficacy in the treatment of pyoderma gangrenosum. , 1982, Archives of dermatology.

[52]  M. D. Freedman,et al.  Anaphylaxis after intravenous methylprednisolone administration. , 1981, JAMA.

[53]  K. Watanabe,et al.  [Pyoderma gangraenosum and cardio-vasculopathies, particularly Takayasu arteritis. Review of the Japanese literature (author's transl)]. , 1981, Annales de dermatologie et de venereologie.

[54]  G. Nuki,et al.  Pyoderma Gangrenosum: CLINICAL AND LABORATORY FINDINGS IN 15 PATIENTS WITH SPECIAL REFERENCE TO POLYARTHRITIS , 1980, Medicine.

[55]  A. Mcdougall,et al.  Splenic infarction and tissue accumulation of crystals associated with the use of clofazimine (Lamprene; B663) in the treatment of pyoderma gangrenosum , 1980, The British journal of dermatology.

[56]  R. Happle,et al.  Ocular involvement in pyoderma gangrenosum. , 1977, Archives of dermatology.

[57]  J. Byrne,et al.  Pyoderma gangrenosum associated with active chronic hepatitis: report of two cases. , 1976, Archives of dermatology.

[58]  G. Wells,et al.  (28) Pyoderma gangrenosum treated with azathioprine and prednisolone , 1974 .

[59]  R. Winkelmann,et al.  Bullous pyoderma gangrenosum and leukemia. , 1972, Archives of dermatology.

[60]  S. Moschella Pyoderma gangrenosum. A patient successfully treated with intralesional injections of steroid. , 1967, Archives of dermatology.

[61]  H. Perry,et al.  Pyoderma Gangrenosum: A Clinical Study of Nineteen Cases , 1957 .